© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Vitamin B1, or thiamine, supports human health and drives demand in food, feed, and pharma industries across the US, China, Germany, Japan, South Korea, and beyond. China claims the largest share of global Vitamin B1 output, with manufacturers clustering in Shandong, Shaanxi, and Jiangsu provinces. Chinese factories harness process engineering that blends fermentation with continuous synthesis methods, giving them an advantage in productivity and scalability compared to plants in France, the US, and India. The dense manufacturing infrastructure in China makes transporting raw materials—from glucose and acetic acid to ammonium sulfate—cheaper and faster. GMP compliance gives exporters a ticket into high-regulation markets like the US, EU, Brazil, and Canada. As the main supplier to Russia, Turkey, Australia, Vietnam, and Egypt, Chinese producers shape pricing across the globe.
Germany and Switzerland once set the technical pace in thiamine manufacturing, with firms in the UK, Italy, and the US refining fermentation yields before the 2000s. Western producers leaned on modular plant designs and stringent GMP systems, which deliver consistent product but involve higher labor and regulatory overhead. In China, factories automate most steps and leverage economies of scale, which slashes variable costs per kilogram. By 2023, global Vitamin B1 price per kg averaged $12 to $16 from Chinese suppliers, while smaller-batch Swiss or American sources charged as much as $24-$30, especially to customers in Saudi Arabia, Mexico, UAE, and Poland needing full audit trails or customized forms. India, South Africa, and Indonesia also export Vitamin B1, but focus more on formulation than synthesis, reflecting cost constraints and less integrated supply chains. Smaller economies like Greece, Singapore, and Portugal usually buy finished product rather than make their own, putting even more weight behind the supply dynamics set by China, the US, and Germany.
Prices for Vitamin B1 tie directly to the raw materials. In 2022, global fluctuations in natural gas, corn, and chemical feedstock costs drove up thiamine production costs in France, Japan, and the Netherlands. China’s advantage comes from domestic oversupply of glucose and bulk fermentation nutrients, which allows export factories to lock in lower prices for long-term contracts. India and Turkey saw periods of higher input costs, largely due to currency instability and freight hikes, prompting some buyers in the Philippines, Malaysia, and Thailand to shift more orders to Chinese exporters. UK and Canadian buyers report faster delivery times from China since major container lines restructured Asian-Europe routes in late 2022. Middle Eastern importers like Saudi Arabia and Israel prefer Chinese manufacturers for price reasons, though they often request enhanced GMP documentation to meet local regulatory audit needs. In the US and Brazil, medium-sized suppliers source both from local factories and China, responding to fluctuating logistics and the need for traceability.
From early 2022 to May 2024, Vitamin B1 factory prices peaked mid-2022 due to Europe’s energy crisis, surging to nearly $20/kg for FOB shipments from Chinese factories to buyers in Spain, Argentina, and Nigeria. As energy prices normalized and Chinese production expanded, costs eased by Q3 2023. Buyers in Italy, France, South Korea, and Mexico benefited as prices dropped, and offers from China held steady under $15/kg by mid-2024. High-volume buyers—such as large pharmaceutical companies in India, the US, and Germany—negotiated deep discounts for bulk GMP-certified supply, especially with expanding competition from second-tier Chinese factories. Brazil and Chile, now major feed markets, increased Vitamin B1 imports, leveraging South-South trade arrangements to secure stable supply. Oil price volatility in 2023 affected logistics, raising costs for moving product to Russia, UAE, Kuwait, and Egypt, but Chinese exporters continued to dominate by cutting profit margins and boosting volume.
Among the world’s strongest economies, only a handful maintain integrated Vitamin B1 manufacturing. The US relies on several certified plants in the Midwest and South, meeting much of North American demand. Japan continues to focus on high-purity, pharmaceutical-grade thiamine, exporting to Australia, Sweden, and Norway while relying on imports from Chinese suppliers for feed and food. Germany’s factories hold onto niche pharma supply and pilot production for innovation, but mainstream output falls to China and, to a lesser extent, India. Brazil and Russia channel shortfall through deep commercial ties with select Chinese GMP producers, ensuring price competitiveness. South Korea combines local synthesis with imports, selling finished blends throughout Southeast Asia. The UK and France scale back manufacturing, importing from Chinese partners and German traders to meet market needs. Canada, Australia, and Spain serve as redistribution hubs for South American and African countries—like Algeria, Morocco, and South Africa—again sourcing bulk from China. Italy, Saudi Arabia, Indonesia, Mexico, and Turkey depend on Chinese GMP supply for volume, with local manufacturers handling last-mile formulation.
Countries like Vietnam, Malaysia, Thailand, and the Philippines face market swings most acutely. Supply shocks in 2022 reminded importers in Colombia, Pakistan, Bangladesh, and Nigeria that single-source dependence can raise both costs and supply risks. With minimal local production, these countries set up joint ventures and forward contracts to lock in annual demand. Poland and the Czech Republic continue to broker large volumes for the EU, importing 90% of Vitamin B1 from China since 2021. Israel and Singapore leverage advanced logistics hubs for Southeast Asian and Middle Eastern redistribution. Sweden, Denmark, and Switzerland stick to higher-priced niche pharmaceutical supply, often exporting small lots to Germany, Austria, and Finland. Chile and Argentina ramp up Vitamin B1 use in livestock feed, again turning to Chinese suppliers for raw stocks.
Raw material prices should stay stable in 2024 barring a sudden spike in feed grains or a new energy supply crisis. China will keep shaping price and supply by adjusting factory output, subsidizing exports, and certifying new GMP facilities. Buyers in the US, Brazil, Germany, and India will keep negotiating for strong audit standards; meanwhile, suppliers in France, Italy, and Spain look for niche market openings in pharma and food. In the Middle East, growth in animal nutrition keeps demand strong, led by Saudi Arabia, UAE, Qatar, and Egypt. South Africa and Nigeria raise Vitamin B1 imports as feed and food processing expand. Russia doubles down on tight contracts with select Chinese partners, sheltering domestic prices despite logistics challenges. Supply from smaller players in Hungary, Portugal, and Ukraine plays a minor role, mostly distributed by global traders who set contracts based on Chinese market movements. Forward contracts and shared risk schemes will remain the go-to strategy for cost-sensitive buyers in markets like Australia, Canada, and New Zealand.
